XOOMAR
Get a free API key

vTv Therapeutics (VTVT)

vTv Therapeutics on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq.

Download CSV

143K

Short interest

settlement 2026-10-15

5.7

Days to cover

+2.4 days vs prior

26.8%

Short share of volume

2026-11-02

18

Fails to deliver

settlement 2026-10-01

Thu 5 Nov

Next earnings

estimated date

$0

Insider flow, 90 days

0 buys, 0 sells

As of 2026-11-02.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 15 October 2026, short interest in VTVT is 143,400 shares, down 16,912 shares over the last month. Over the last 48 readings it ranged from 14,634 shares (15 July 2025) to 172,198 shares (15 July 2026). At the reported average volume of 25K shares a day that is 5.7 days to cover.

Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/vtvt" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-10-15143,400-8.5%25,2535.68
2026-09-30156,754-2.2%47,5623.30
2026-09-15160,312-1.6%31,7825.04
2026-08-31162,908-1.9%59,6662.73
2026-08-14166,003+0.1%105,0981.58
2026-07-31165,792-3.7%112,2891.48
2026-07-15172,198+5.2%60,9182.83
2026-06-30163,681+3.3%70,4432.32
2026-06-15158,523+0.8%33,7784.69
2026-05-29157,260+8.8%44,8493.51
2026-05-15144,573+5.6%39,8853.62
2026-04-30136,961+21.5%71,6221.91
2026-04-15112,740+37.1%53,2252.12
2026-03-3182,236+24.6%46,1881.78
2026-03-1365,987+15.6%93,8891.00
2026-02-2757,087+12.3%25,0982.27
2026-02-1350,829+61.2%28,3491.79
2026-01-3031,525+2.0%13,2772.37
2026-01-1530,900+14.0%30,0901.03
2025-12-3127,101+62.3%14,7471.84
2025-12-1516,694-12.8%10,0401.66
2025-11-2819,140-9.3%14,5171.32
2025-11-1421,103+8.4%11,6171.82
2025-10-3119,468-14.7%3,1956.09
2025-10-1522,809+6.2%5,0754.49
2025-09-3021,469+25.6%5,7563.73
2025-09-1517,092+16.3%5,4333.15
2025-08-2914,692-7.2%1,02614.32
2025-08-1515,827+3.8%1,51810.43
2025-07-3115,248+4.2%1,27411.97
2025-07-1514,634-19.9%5,1432.85
2025-06-3018,258+1.5%10,2631.78
2025-06-1317,995-3.9%2,8766.26
2025-05-3018,719+14.5%4,4164.24
2025-05-1516,345-24.4%6,6662.45
2025-04-3021,625-5.7%11,6131.86
2025-04-1522,921+42.4%12,8521.78
2025-03-3116,094-34.3%78,0641.00
2025-03-1424,476+1.6%9,9042.47
2025-02-2824,089-13.8%11,4942.10
2025-02-1427,933+4.6%10,8282.58
2025-01-3126,716+18.9%6,5134.10
2025-01-1522,468+33.1%10,4212.16
2024-12-3116,883-0.0%8,0482.10
2024-12-1316,884-25.0%45,1941.00
2024-11-2922,506-17.2%26,8671.00
2024-11-1527,191-5.8%59,3961.00
2024-10-3128,850-0.4%28,5221.01

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 2 November 2026, the short share of VTVT volume is 26.8%, down 11.3 points over the last five sessions. Over the last 30 readings it ranged from 25.5% (16 October 2026) to 83.6% (8 October 2026). The latest reading sits at the bottom of that range. The latest reading is 28.7 points below the 30-session average of 55.5%, on 11K shares reported.

DateShort volumeTotal volumeShort shareExempt
2026-11-023K11K26.8%0
2026-10-302K5K49.2%0
2026-10-292K4K54.3%0
2026-10-282K4K47.1%0
2026-10-272K3K49.6%0
2026-10-262K6K38.1%0
2026-10-231K3K39.7%0
2026-10-221K3K46.7%0
2026-10-212K4K67.3%0
2026-10-203K4K76.8%0
2026-10-192K4K48.5%0
2026-10-162K7K25.5%0
2026-10-156K7K78.6%0
2026-10-144K6K71.0%21
2026-10-134K16K27.1%0
2026-10-124K6K68.0%0
2026-10-093K6K43.3%0
2026-10-086K7K83.6%160
2026-10-074K5K66.5%0
2026-10-064K8K50.9%0
2026-10-054K8K49.5%400
2026-10-024K8K49.9%0
2026-10-017K9K77.3%0
2026-09-304K6K57.9%0
2026-09-294K9K37.3%0
2026-09-288K12K63.0%0
2026-09-255K11K43.5%0
2026-09-245K7K78.6%0
2026-09-235K6K74.8%0
2026-09-221K2K75.2%0

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 1 October 2026, the fails-to-deliver balance in VTVT is 18 shares, down 2,282 shares over the last settlement date. Over the last 30 readings it ranged from 2 shares (6 April 2026) to 4,412 shares (28 August 2026). The latest reading sits at the bottom of that range.

SettlementShares failedPriceValue
2026-10-0118$30.84$555
2026-09-112,300$31.86$73K
2026-09-08157$33.35$5K
2026-08-284,412$32.80$145K
2026-08-272,913$33.57$98K
2026-08-26164$33.91$6K
2026-08-191,261$31.48$40K
2026-08-18671$31.31$21K
2026-08-14178$30.85$5K
2026-08-1180$34.29$3K
2026-08-07174$34.61$6K
2026-08-0678$34.39$3K
2026-07-213,928$32.38$127K
2026-07-15499$31.88$16K
2026-06-2999$35.08$3K
2026-06-26177$36.82$7K
2026-06-18685$33.92$23K
2026-06-1733$32.24$1K
2026-06-1510$32.77$328
2026-05-2965$33.50$2K
2026-05-28118$33.72$4K
2026-05-27143$33.16$5K
2026-05-1947$35.49$2K
2026-05-15405$38.43$16K
2026-05-082$31.04$62
2026-05-0513$32.50$423
2026-04-301,600$31.27$50K
2026-04-10171$37.30$6K
2026-04-062$41.17$82
2026-04-01396$39.66$16K

Insider trades

SEC Form 4, newest first. JSON

No open-market insider trades were reported for VTVT in the last 90 days. The most recent filings are listed below. Latest filing: AKKARAJU SRINIVAS (Director) on 2025-09-22.

DateInsiderTitleTypeSharesPriceValueOwned after
2025-09-22AKKARAJU SRINIVASDirectorGrant106K$15.27$1.6M106K
2025-09-03BAKER JULIANDirectorGrant4Kprice not stated in the filingnot stated12K
2025-09-03BAKER JULIANDirectorGrant47Kprice not stated in the filingnot stated136K
2024-11-18SEKHRI PAUL JPres, CEO and Exec ChairpersonBuy2K$16.96$31K5K
2024-11-15SEKHRI PAUL JPres, CEO and Exec ChairpersonBuy1K$16.35$23K1K
2024-11-15SEKHRI PAUL JPres, CEO and Exec ChairpersonBuy2K$16.88$30K3K
2024-03-05AKKARAJU SRINIVASDirector,TenPercentOwnerReturned to company59Kprice not stated in the filingnot stated207K
2024-03-05Samsara BioCapital, L.P.TenPercentOwnerOther transaction59Kprice not stated in the filingnot stated207K
2024-03-05667, L.P.DirectorReturned to company53K$0.00$089K
2024-03-05667, L.P.DirectorReturned to company5K$0.00$08K
2024-02-27AKKARAJU SRINIVASDirector,TenPercentOwnerGrant225K$11.81$2.7M266K
2022-11-29FRY JOHN ADirectorBuy40K$0.83$34K61K
2022-11-28FRY JOHN ADirectorBuy21K$0.83$17K21K
2021-12-20PERELMAN RONALD OTenPercentOwnerSell87K$1.15$100K36.5M
2021-02-26KOZLOV HERSHDirectorBuy10K$2.74$27K25K
2021-02-26Nelson Rich S.DirectorBuy10K$2.86$29K10K
2021-02-26Nelson Rich S.DirectorBuy50K$2.86$143K50K
2020-12-17PERELMAN RONALD OTenPercentOwnerBuy625K$1.60$1.0M36.6M
2020-12-10PERELMAN RONALD OTenPercentOwnerBuy625K$1.60$1.0M36.0M
2020-11-24PERELMAN RONALD OTenPercentOwnerBuy625K$1.60$1.0M35.4M
2020-05-15KOZLOV HERSHDirectorBuy10K$3.00$30K15K
2020-05-12PERELMAN RONALD OTenPercentOwnerBuy625K$1.60$1.0M34.7M
2020-03-10KINDLER JEFFREY BDirectorExercise or conversion12K$0.00$035K
2020-02-25PERELMAN RONALD OTenPercentOwnerBuy1.3M$1.60$2.0M34.1M
2020-01-28PERELMAN RONALD OTenPercentOwnerBuy1.3M$1.60$2.0M32.9M
2020-01-07PERELMAN RONALD OTenPercentOwnerBuy1.3M$1.60$2.0M31.6M

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

12 holders report 5% or more of VTVT in their latest filing, 3 on Schedule 13D (active intent). The largest reported stake is Srinivas Akkaraju at 9.9% of the class (403,942 shares), filed 2025-12-09 for an event on 2025-12-08.

FiledFormHolderSharesOf classEvent
2026-10-0813G/Ano. 3Israel A. Englanderindividual342K8.7%2026-09-30
2026-10-0813G/Ano. 3Millennium Management LLCother entity342K8.7%2026-09-30
2026-10-0813G/Ano. 3Millennium Group Management LLCother entity342K8.7%2026-09-30
2026-10-0813G/Ano. 3Integrated Core Strategies (US) LLCother entity312K7.9%2026-09-30
2025-12-0913D/Ano. 3Srinivas Akkarajuindividual404K9.9%2025-12-08
2025-12-0913D/Ano. 3Samsara BioCapital GP, LLCother entity246K6.2%2025-12-08
2025-12-0913D/Ano. 3Samsara BioCapital, L.P.partnership246K6.2%2025-12-08
2025-12-0913D/Ano. 3Samsara Opportunity Fund GP, LLCother entity153K3.8%2025-12-08
2025-12-0913D/Ano. 3Samsara Opportunity Fund, L.P.partnership153K3.8%2025-12-08
2025-11-1213G/Ano. 1Raymond Debbaneindividual393K9.4%2025-09-30
2025-11-1213G/Ano. 1Siren, L.L.C.other entity346K8.4%2025-09-30
2025-11-1213G/Ano. 1Invus Public Equities Advisors, LLCother entity346K8.4%2025-09-30
2025-11-1213G/Ano. 1Invus Public Equities, L.P.partnership346K8.4%2025-09-30
2025-11-1213G/Ano. 1Invus Global Management, LLCother entity346K8.4%2025-09-30
2025-11-1213G/Ano. 1Avicenna Life Sci Master GP LLCother entity47K1.2%2025-09-30
2025-11-1213G/Ano. 1Avicenna Life Sci Master Fund LPpartnership47K1.2%2025-09-30
2025-11-1213G/Ano. 1Ulys, L.L.C.other entity47K1.2%2025-09-30

13F holders

Tracked managers holding VTVT at their latest 13F. JSON

5 of the 30 tracked managers held VTVT at their latest 13F, $11.7M in total at quarter-end prices. Millennium Management is the largest at $10.2M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 5 added shares and 0 cut.

FundQuarterSharesValueOf portfolioChange in shares
Millennium Management2026-06-30270K$10.2M0.00%+64K
Renaissance Technologies2026-06-3017K$657K0.00%new
Two Sigma Investments2026-06-3011K$432K0.00%new
Point72 Asset Management2026-06-306K$224K0.00%new
Citadel Advisors2026-06-306K$222K0.00%new

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

What this page is

vTv Therapeutics in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows vTv Therapeutics (VTVT), SEC CIK 1641489, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest
FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Daily short volume
FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-01.JSON and CSV
Large holders
SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-08.JSON and CSV
13F holders
SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Earnings dates
SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-06.JSON and CSV
Insider trades
SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2025-09-22.JSON and CSV
Company record
EDGAR filing index for CIK 1641489Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
10 requests a minute without a key, 30 with a free key from a free account.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Other company pages

Datasets

Frequently Asked Questions

How much of VTVT is sold short?
143,400 shares were held short at the 2026-10-15 settlement, 5.7 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is VTVT's daily short volume?
On 2026-11-02, 2,946 of the 11,005 VTVT shares reported to FINRA were sold short, 26.8% of the day's reported volume. Short volume is a flow for one day, not a position.
Does VTVT have fails to deliver?
The SEC's latest file shows 18 VTVT shares failed to deliver at settlement 2026-10-01. Fails are reported per settlement date and published twice a month with a lag.
Are VTVT insiders buying or selling?
No open-market insider trades were reported for VTVT in the last 90 days. The most recent filings are listed below. Latest filing: AKKARAJU SRINIVAS (Director) on 2025-09-22.
Who owns 5% or more of VTVT?
12 holders report 5% or more of VTVT in their latest filing, 3 on Schedule 13D (active intent). The largest reported stake is Srinivas Akkaraju at 9.9% of the class (403,942 shares), filed 2025-12-09 for an event on 2025-12-08.
Which tracked 13F managers own VTVT?
5 of the 30 tracked 13F managers held VTVT shares at their latest filing, $11.7M in all. The largest: Izzy Englander's Millennium Management (270K shares, $10.2M), Renaissance Technologies (17K shares, $657K), Two Sigma Investments (11K shares, $432K), Steve Cohen's Point72 Asset Management (6K shares, $224K), Ken Griffin's Citadel Advisors (6K shares, $222K).

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.